SG Americas Securities
ITOS

SG Americas Securities’s iTeos Therapeutics ITOS Stock Holding History

SG Americas Securities’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,498
Closed -$81K – 3263
2025
Q1 		$81K Sell
13,498
-368
-3% -$2.7K ﹤0.01% 3107
2024
Q4 		$106K Buy
13,866
+1,508
+12% +$13K ﹤0.01% 2703
2024
Q3 		$126K Buy
+12,358
New +$189K ﹤0.01% 2876
2024
Q2 		– Sell
-9,614
Closed -$131K – 3066
2024
Q1 		$131K Sell
9,614
-5,136
-35% -$56K ﹤0.01% 2331
2023
Q4 		$162K Buy
+14,750
New +$146K ﹤0.01% 2355
2022
Q3 		– Sell
-61,193
Closed -$1.26M – 3364
2022
Q2 		$1.26M Buy
61,193
+1,197
+2% +$28.4K 0.01% 1104
2022
Q1 		$1.93M Buy
59,996
+53,046
+763% +$1.93M 0.01% 941
2021
Q4 		$324K Sell
6,950
-7,265
-51% -$242K ﹤0.01% 2404
2021
Q3 		$384K Buy
+14,215
New +$372K ﹤0.01% 2730
2021
Q2 		– Sell
-4,244
Closed -$145K – 3041
2021
Q1 		$145K Buy
+4,244
New +$153K ﹤0.01% 2880
2020
Q4 		– Sell
-4,532
Closed -$112K – 3403
2020
Q3 		$112K Buy
+4,532
New +$122K ﹤0.01% 2422

Other funds holding ITOS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SG Americas Securities's ITOS Position: Q2 2025 in Review

SG Americas Securities sold out of iTeos Therapeutics (ITOS) in Q2 2025, closing a stake of 13,498 shares — an estimated $81K sold.

SG Americas Securities first reported a position in ITOS in Q3 2020 and held it in 11 quarters. The position peaked at $1.93M in Q1 2022. 136 funds tracked by Wall St. Rank hold ITOS as of Q2 2025.

  • SG Americas Securities reported no remaining iTeos Therapeutics position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 13,498 iTeos Therapeutics shares in Q2 2025, an estimated $81K.
  • SG Americas Securities first reported a position in iTeos Therapeutics in Q3 2020 and held it in 11 quarters.
  • SG Americas Securities's iTeos Therapeutics position peaked at $1.93M in Q1 2022.
  • 136 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.